EC Nutrition

The Beljanski Foundation is sponsoring a new clinical trial for patients with Long COVID because of the urgent need for a new and successful treatment. The goal is to test whether administration of a special preparation of small RNA fragments resolves symptoms in Long COVID patients. Originally developed by M. Beljanski, the fragments work by stimulating stem cells in bone marrow to produce our immune cells. Previous research conducted on this special preparation of small RNA fragments at Cancer Treatment Centers of America confirmed their safety and effectiveness for treating thrombocytopenia (low platelets) caused by chemotherapy.  Thrombocytopenia, as well as immune dysregulation, have been seen in a significant number of Long COVID patients and low platelets are associated with fatigue, a major symptom of Long COVID. The trial will also reveal the potential of the RNA fragments to re-balance immunity in these patients. .

Keywords: Long Covid; COVID-19; SARS-CoV-2; Platelets; Thrombocytopenia; Clinical Trial

1. Nearly One in Five American Adults Who Have Had COVID-19 Still Have “Long COVID” (2022).
2. Groff Destin., et al. “Short-term and Long-term Rates of Postacute Sequelae of SARS-CoV-2 Infection: A Systematic Review”. JAMA Network Open10 (2021): e2128568.
3. https://covid19.who.int/
4. Davis Hannah E., et al. “Long COVID: Major Findings, Mechanisms and Recommendations”. Nature Reviews Microbiology 21 (2023): 133-146.
5. https://www.cdc.gov/coronavirus/2019-ncov/long-term-effects/index.html#:~:text=People%20with%20post%2DCOVID%20conditions%20(or%20long%20COVID)%20may,away%20or%20come%20back%20again
6. Davis Hannah E., et al. “Characterizing long COVID in an international cohort: 7 months of symptoms and their impact”. Eclinical Medicine 38 (2021): 101019.
7. Manne Bhanu Kanth., et al. “Platelet gene expression and function in patients with COVID-19”. Blood11 (2020): 1317-1329.
8. Jiang Shi-Qin., et al. “The association between severe COVID-19 and low platelet count: evidence from 31 observational studies involving 7613 participants”. British Journal of Haematology1 (2020): e29-e33.
9. Rohlfing Anne-Katrin., et al. “Platelets and COVID-19”. Hamostaseologie5 (2021): 379-385.
10. Bhattacharjee Sukrita and Mainak Banerjee. “Immune Thrombocytopenia Secondary to COVID-19: a Systematic Review”. SN Comprehensive Clinical Medicine11 (2020): 2048-2058.
11. Raadsen Matthijs., et al. “Thrombocytopenia in Virus Infections”. Journal of Clinical Medicine4 (2021): 877.
12. Hottz Eugenio D., et al. “Platelets in Immune Response to Virus and Immunopathology of Viral Infections”. Frontiers in Medicine 5 (2018): 121.
13. Seyoum Masresha., et al. “Human blood platelets and viruses: defense mechanism and role in the removal of viral pathogens”. Thrombosis Journal16 (2018).
14. Shen Shu., et al. “SARS-CoV-2 interacts with platelets and megakaryocytes via ACE2-independent mechanism”. Journal of Hematology and Oncology1 (2021).
15. Zhu Aiwei., et al. “Infection of lung megakaryocytes and platelets by SARS-CoV-2 anticipate fatal COVID-19”. Cellular and Molecular Life Sciences: CMLS7 (2022): 365.
16. Assinger Alice. “Platelets and infection - an emerging role of platelets in viral infection”. Frontiers in Immunology 5 (2014): 649.
17. Estevez Brian and Xiaoping Du. “New Concepts and Mechanisms of Platelet Activation Signaling”. Physiology2 (2017): 162-177.
18. Koupenova Milka., et al. “Circulating Platelets as Mediators of Immunity, Inflammation, and Thrombosis”. Circulation Research2 (2018): 337-351.
19. Jevtic Stefan D and Ishac Nazy. “The COVID Complex: A Review of Platelet Activation and Immune Complexes in COVID-19”. Frontiers in Immunology 13 (2022): 807934.
20. Cloutier Nathalie., et al. “Platelets Release Pathogenic Serotonin and Return to Circulation After Immune Complex-mediated Sequestration”. Proceedings of the National Academy of Sciences of the United States of America7 (2018).
21. Maclean Jessica A and Simone M Schoenwaelder. “Serotonin in Platelets”. Serotonin: The Mediator That Spans Evolution, Academic Press (2019): 91-119.
22. Song Fey and Al-Samkari H. "Management of Adult Patients with Immune Thrombocytopenia (ITP): A Review on Current Guidance and Experience from Clinical Practice”. Journal of Blood Medicine 12 (2021): 653-664.
23. Alonso-Beato Rubén., et al. “Immune thrombocytopenia and COVID-19: Case report and review of literature”. Lupus9 (2021): 1515-1521.
24. Hershey AD and M Chase. “Independent functions of viral protein and nucleic acid in growth of bacteriophage”. The Journal of General Physiology1 (1952): 39-56.
25. Mirko Beljanski. “The Regulation of DNA and Transcription”. 1^st Karger, 1983, 3^rd edition. Demos Medical Publishing. USA (1983).
26. Schweet R and R Heintz. “Protein synthesis”. Annual Review of Biochemistry 35 (1966): 723-758.
27. Grimble GK. “Why are dietary nucleotides essential nutrients?”. The British Journal of Nutrition4 (1996): 475-478.
28. Grimble GK. “Dietary nucleotides and gut mucosal defence”. Gut1 (1994): S46-51.
29. López-Navarro AT., et al. “Morphological changes in hepatocytes of rats deprived of dietary nucleotides”. The British Journal of Nutrition4 (1996): 579-589.
30. Beljanski Mirko., et al. “Nouvelles substances (R.L.B.) actives dans la leucopoïese et la formation des plaquettes”. Bulletin de l'Académie Nationale de Médecine162 (1978): 475-781.
31. Beljanski Mirko and Plawecki M. “Particular RNA fragments as promoters of leukocyte and platelet formation in rabbits”. Experimental Cell Biology3 (1979): 218-225.
32. Donadio D., et al. “RNA Fragments (RLB) And Tolerance Of Cytostatic Treatments In Hematology: A Preliminary Study About Two Non-Hodgkin Malignant Lymphoma Cases”. Deutsche Zeitschrift für Onkologie2 (1991): 33-35.
33. Sapp J. “Jean Brachet, l'hérédité générale and the origins of molecular embryology”. History and Philosophy of the Life Sciences1 (1997): 69-87.
34. Ochoa Severo and Kornberg A. “Discoveries of The Mechanism In The Biological Synthesis Of Ribonucleic Acids (RNA) And Deoxyribonucleic Acids (DNA)”. The Chemical Engineering Journal43 (1959): 19-20.
35. Okazaki R., et al. “Mechanism of DNA chain growth. I. Possible discontinuity and unusual secondary structure of newly synthesized chains”. Proceedings of the National Academy of Sciences of the United States of America2 (1968): 598-605.
36. Levin Robert D., et al. “Dose escalation study of an anti-thrombocytopenic agent in patients with chemotherapy induced thrombocytopenia”. BMC Cancer 10 (2010): 565.